Amyloid‐β PET and CSF in an autopsy‐confirmed cohort

by Juhan Reimand, Baayla D. C. Boon, Lyduine E. Collij, Charlotte E. Teunissen, Annemieke J. M. Rozemuller, Bart N. M. vanBerckel, Philip Scheltens, Rik Ossenkoppele, Femke Bouwman
Published 2020-11-01

Discordant amyloid-β PET and CSF biomarkers and its clinical consequences

by Arno de Wilde, Juhan Reimand, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Femke Bouwman, Rik Ossenkoppele
Published 2019-09-01

PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases

by Juhan Reimand, Arno de Wilde, Charlotte E. Teunissen, Marissa Zwan, Albert D. Windhorst, Ronald Boellaard, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Bart N. M. van Berckel, Rik Ossenkoppele, Femke Bouwman
Published 2019-12-01

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers

by Rik Ossenkoppele, Juhan Reimand, Ruben Smith, Antoine Leuzy, Olof Strandberg, Sebastian Palmqvist, Erik Stomrud, Henrik Zetterberg, the Alzheimer's Disease Neuroimaging Initiative, Philip Scheltens, Jeffrey L Dage, Femke Bouwman, Kaj Blennow, Niklas Mattsson‐Carlgren, Shorena Janelidze, Oskar Hansson
Published 2021-08-01